Banka BioLoo (BANKA) delivered a robust Q1 FY26-27 performance!

Revenue climbed 20.5% YoY to ₹16.4 Cr, EBITDA surged 46.6% to ₹1.51 Cr, and PAT impressively jumped 162.3% to ₹0.37 Cr.

Growth is fueled by strategic expansion into key metros like Bangalore and Mumbai, securing projects with Brigade, Reliance, and RMZ.

The company also won orders with Auro Infra and multiple bio-toilet projects in Hyderabad.

A major long-term driver is its Megaliter Varunaa subsidiary, now with 15 projects, 11.7 MLD treatment capacity, and a significant Net LTV of ₹122 Cr.

This portfolio ensures sustained revenue visibility for 7-10 years.

With an unexecuted order book of ₹82 Cr, management expects strong future revenue.

The focus remains on leveraging this contracted business and long-term value creation as Megaliter's projects mature.